BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McLaughlin MM, Miglis C, Skoglund E, Wagner J, Advincula MR, Scheetz MH. Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections. J Glob Antimicrob Resist 2018;13:261-3. [PMID: 29432939 DOI: 10.1016/j.jgar.2018.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Laupland KB, Pasquill K, Parfitt EC, Dagasso G, Gupta K, Steele L. Inhospital death is a biased measure of fatal outcome from bloodstream infection. Clin Epidemiol 2019;11:47-52. [PMID: 30655704 DOI: 10.2147/CLEP.S187381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
2 Gunter SG, Barber KE, Wagner JL, Stover KR. Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae. Antibiotics (Basel) 2020;9:E331. [PMID: 32560457 DOI: 10.3390/antibiotics9060331] [Reference Citation Analysis]